GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $878,000 | +73.2% | 5,210 | 0.0% | 0.04% | +66.7% |
| Q4 2018 | $507,000 | -43.7% | 5,210 | 0.0% | 0.02% | -38.5% |
| Q3 2018 | $900,000 | +23.8% | 5,210 | 0.0% | 0.04% | +14.7% |
| Q2 2018 | $727,000 | +23.9% | 5,210 | 0.0% | 0.03% | +41.7% |
| Q1 2018 | $587,000 | -14.7% | 5,210 | 0.0% | 0.02% | -25.0% |
| Q4 2017 | $688,000 | +27.9% | 5,210 | -1.7% | 0.03% | +14.3% |
| Q3 2017 | $538,000 | -54.6% | 5,300 | -45.9% | 0.03% | -58.2% |
| Q1 2017 | $1,185,000 | – | 9,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |